内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Belanoff Joseph K. Director active across 1 company, notably CORCEPT THERAPEUTICS INC. In total, 22 disclosures have been published. Split: 0 buy · 16 sells. Total volume traded: €17.2m. Activity tracked since 6 July 2022. The latest transaction was filed on 1 June 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Belanoff Joseph K
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报22 总计
12,837 股@ US$69.740.0071% mcap6.2% 占其流量Common StockSEC:0001193125-26-253459:3
300,000 股0Common StockSEC:0001193125-26-253459:0
150,000 股0Common StockSEC:0001193125-26-253459:1
150,000 股0Common StockSEC:0001193125-26-253459:2
40,000 股@ US$50.09650.016% mcap13.8% 占其流量Common StockSEC:0001193125-26-206540:0
26,198 股@ US$50.07358.1% 占其流量Common StockSEC:0001193125-26-129143:0
550,000 股@ US$3.888.2% 占其流量Common StockSEC:0001193125-25-335538:0
40,000 股@ US$79.769913.6% 占其流量Common StockSEC:0001193125-25-307204:0
11,218 股@ US$74.07864.1% 占其流量Common StockSEC:0001193125-25-267545:0
5,616 股@ US$84.28952.4% 占其流量Common StockSEC:0001193125-25-230467:0
39,300 股@ US$70.517214.6% 占其流量Common StockSEC:0001193125-25-196313:0
16,745 股@ US$67.80638.0% 占其流量Common StockSEC:0000950170-25-103323:0
17,809 股@ US$68.86898.6% 占其流量Common StockSEC:0000950170-25-103323:1
5,446 股@ US$69.64832.7% 占其流量Common StockSEC:0000950170-25-103323:2
615 股@ US$73.68730.3% 占其流量Common StockSEC:0000950170-25-097372:0
4,881 股@ US$78.42112.6% 占其流量Common StockSEC:0000950170-25-081939:0
18,480 股@ US$72.51879.6% 占其流量Common StockSEC:0000950170-25-063831:0
35,102 股@ US$94.7224.7% 占其流量Common StockSEC:0000950170-25-049790:0
1,974 股@ US$60.83290.9% 占其流量Common StockSEC:0000950170-25-045433:0
2,924 股@ US$60.9091.4% 占其流量Common StockSEC:0000950170-25-032740:0
450,000 股@ US$3.2911.0% 占其流量Common StockSEC:0000950170-24-090052:0
800,000 股@ US$2.0813.2% 占其流量Common StockSEC:0000899243-22-025827:0
About Belanoff Joseph K
BELANOFF JOSEPH K is a declarant linked to CORCEPT THERAPEUTICS INC, where he is Chief Executive Officer. He has 22 filings in total, and in the sampled recent filings from 2022-07-08 to 2026-06-02, sell transactions total EUR 17179180 and the most frequent transaction nature is Cession.